FIELD: experimental medicine.
SUBSTANCE: invention relates to experimental medicine and can be used to optimize treatment regimens for B16 melanoma in laboratory animals. To do this, the compound aminodihydrophthalazinedione sodium at a dose of 5 mg/mouse is administered intraperitoneally twice a week one week after inoculation of a B16 melanoma tumor with a total course of 10 injections.
EFFECT: invention provides increase in survival rate and decrease in tumor volume in the treatment of B16 melanoma in laboratory animals in the experiment.
1 cl, 1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITION OF MELANOMA GROWTH IN TUMOUR-BEARING MICE | 2023 |
|
RU2813701C2 |
| METHOD FOR REDUCING MELANOMA B-16 DISSEMINATION | 2005 |
|
RU2308096C2 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| METHOD FOR REDUCING PULMONARY LEWIS CARCINOMA DISSEMINATION | 2005 |
|
RU2308097C2 |
| METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
| METHOD OF PHOTODYNAMIC THERAPY OF TRANSPLANTED ECTODERMAL TUMOR OF MELANOMA B16 OF MICE | 2020 |
|
RU2724867C2 |
| ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
| METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
| METHOD FOR POTENTIATING ACTIVITY OF ANTI-TUMOUR CYTOTOXIC PREPARATIONS | 2017 |
|
RU2714140C2 |
| AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
